Cite
HARVARD Citation
Vidal, L. et al. (2019). Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia – an updated meta‐analysis. British journal of haematology. pp. 234-242. [Online].